Update June 6, 2025: Circle’s debut on the NYSE exceeded expectations. Shares of CRCL opened at $69, more than doubling the IPO price of $31. After reaching an intraday high of $103.75, the stock ...
Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that its Trials in Progress abstract has been selected for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results